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Abstract We here show that bone morphogenetic protein
(BMP) 7 acted in synergy with the distinct type of cytokines,
leukemia inhibitory factor (LIF) and interleukin (IL) 6 that are
in the IL-6 family, to induce astrocyte differentiation from
neuroepithelial cells as assessed by expression of glial fibrillary
acidic protein (GFAP). In this synergistic action, transcription
factors, Smads and STAT3 (for signal transducer and activator
of transcription 3) activated by respective group of cytokines, as
well as a transcriptional coactivator p300 were essential. Taken
together with our previous finding that the synergistic astrocyte
induction by BMP2 and LIF is attributed to the complex
formation of Smads and STAT3 bridged by p300, it is
conceivable that this complex formation is a mechanism utilized
in common by two different types of cytokines belonging to the
BMP and IL-6 families in order to synergistically induce
astrocyte differentiation. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The central nervous system is organized by neuronal and
glial cells generated from common neural precursor cells in
the developing brain [1], and fate decision of the precursors is
regulated by cell-intrinsic programs as well as extrinsic cues
from surrounding environment. Cytokine signaling is one of
such extrinsic cues. For instance, it has been indicated that
astrocyte di¡erentiaton from neural precursors is induced in a
culture for 3^7 days either with BMPs such as BMP2 and
BMP4 or with IL-6 family of cytokines like IL-6, IL-11,
LIF, ciliary neurotrophic factor and oncostatin M [2^9].
BMPs belong to the transforming growth factor (TGF)-L
superfamily and were initially identi¢ed based on the osteoin-
ductive property. BMPs are known to signal through hetero-
tetrameric serine/threonine kinase receptors comprising two
molecules each of type I and II receptor components. Acti-
vated receptors phosphorylate transcription factors Smad1,
Smad5 or Smad8, which allows them to associate with a com-
mon mediator, Smad4, leading to transactivation of target
genes [10].
IL-6 family of cytokines are pluripotent and characterized
by the requirement of membrane glycoprotein gp130 in their
functional receptor complexes for signal transduction. In re-
sponse to the binding of IL-6 family of cytokines to their
speci¢c receptors, gp130 becomes dimerized either with itself
or with another dimer partner like LIF receptor (LIFR) or
oncostatin M receptor. This dimer formation triggers the ac-
tivation of associated Janus kinases and downstream tran-
scription factor STAT3 [11].
Considering that various cytokines exist simultaneously in
the physiological condition which may stimulate cells at the
same time, it is important to take a possible crosstalk between
various types of cytokine signals into account when trying to
elucidate bona ¢de function of cytokines in vivo. We have
previously found that BMP2 and LIF synergistically induce
astrocyte di¡erentiation of neuroepithelial cells [6]. This syn-
ergistic e¡ect has been shown to be explained by cytokine
signal-dependent formation of a complex of Smad1 and
STAT3 bridged by a transcriptional coactivator p300 which
e¡ectively transactivates target genes such as the one for
GFAP, an astrocyte marker. In this study, we have observed
expression of BMP7, another member of the BMP family, in
fetal mouse brain and cultured neuroepithelial cells, implying
a role of BMP7 in fate determination of neural precursors. We
further demonstrate that BMP7 was capable of cooperating
with LIF and IL-6 to induce astrocyte di¡erentiation from
neuroepithelial cells through the mechanism analogous to
that utilized by BMP2 and LIF.
2. Materials and methods
2.1. Neuroepithelial cell culture
Neuroepithelial cells were isolated from telencephalons of embry-
onic day (E) 14.5 mice as previously described [5,6]. Dissociated cells
were cultured for 4 days in N2-supplemented DMEM/F12 medium
containing 10 ng/ml of basic ¢broblast growth factor (RpD Systems)
on a 90 mm dish that had been precoated with poly-L-ornithine (Sig-
ma) and ¢bronectin (Gibco BRL). 4 days later, cells were then de-
tached in HBSS and replated for further experiments. All the cyto-
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kines used in this study (LIF (Gibco), IL-6 and soluble IL-6 receptor
(sIL-6R) (kindly provided by Dr. K. Yasukawa, Tosoh Corp), BMP7
(kindly provided by Dr. K. Miyazono, The University of Tokyo), and
TGF-L1 (RpD Systems)) were supplemented at a concentration of
80 ng/ml, excepted for sIL-6R (500 ng/ml).
2.2. Reverse transcription-polymerase chain reaction (RT-PCR)
RT-PCR was performed as previously described [9]. Used primer
sets were as follows: 5P-CGATTTCAGCCTGGACAACG-3P, 5P-
CCTGGGTACTGAACACGG-3P (for BMP7); 5P-CCGGAGAG-
CCCTGGATACC-3P, 5P- AGAGGGCAAGGACCTTGCTG-3P (for
TGF-L1); 5P-GGTCTCTGCTTTGTCTCAGTC-3P, 5P-AGACTGG-
ACCAGCAATGACAG-3P (for TLR I); 5P-CGGTCAAGGTTCCA-
CAGCTGTGC-3P, 5P-GGTCGTCCTCCAGGATGATGGCA-3P (for
TLR II); 5P-GTCGTCCATCTTGCCATTCAC-3P, 5P-GTTGTGTC-
CCACTGATCTACC-3P (for Smad2); 5P-TGCTGGGTTGGAA-
GAAGGGC-3P, 5P-TGTTGAAGGCAAACTCACAGAG-3P (for
Smad3).
2.3. Immunocytochemical staining
Immunocytochemical staining was performed as previously de-
scribed [5,6]. Brie£y, cells cultured for 2 days on chamber slides which
had been precoated as described above were ¢xed in 4% paraformal-
dehyde in PBS and stained with anti-GFAP antibody (DAKO) and
rhodamine-conjugated secondary antibody (CHEMICON) for detec-
tion of astrocytes. Bisbenzimide H33258 £uorochrome trihydrochlo-
ride (Nacalai Tesque) was used to stain nuclei.
2.4. GFAP promoter assay
GFAP promoter assay was performed as previously described [6].
Brie£y, neuroepithelial cells replated on 12-well plates which had been
precoated as described above were transfected with a plasmid contain-
ing ¢re£y luciferase gene regulated by 2.5 kb GFAP gene promoter
(GF1L-pGL3) [6] using TransIt LT-1 (Mirus). Control transfection
was made with sea pansy luciferase gene conjugated with human
elongation factor 1K promoter pEF-Rluc. On the following day, cells
were stimulated with cytokines for 8 h and solubilized. Luciferase
activities in the cell lysates were assessed using Pikkagene Dual Lu-
ciferase Assay System (Toyo Ink Inc.) with MicroLumat LB96P
(WALLAC BERTHOLD) luminometer.
3. Results
3.1. Expression of BMP7 in fetal mouse brain and cultured
neuroepithelial cells
BMP family of cytokines are divided into osteogenic pro-
tein-1 group, BMP2 group and growth di¡erentiation factor-5
group [12]. We have previously shown that BMP2 is expressed
in fetal mouse brain and cultured neuroepithelial cells, and
induces astrocyte di¡erentiation in a synergistic manner in
cooperation with an IL-6 family of cytokine, LIF [6,7]. How-
ever, it remains elusive whether other members of the BMP
family contribute to the induction of astrocyte di¡erentiation
from neuroepithelial cells. Thus, we ¢rst examined the expres-
sion of BMP7, a member of the osteogenic protein-1 group in
the BMP family. As shown in Fig. 1, transcripts for BMP7
were detectable in mouse brain on E17.5, the time when as-
trocytes are considered to emerge in vivo, and also in 4 days
cultured neuroepithelial cells. Together with our previous data
showing the expression of BMP receptors (type I and II) in
the fetal brain and neuroepithelial cells [7], it seems likely that
BMP7 may play a role in fate determination of neural pre-
cursors in the developing brain.
3.2. Synergistic astrocyte di¡erentiation induced by BMP7 and
LIF
In light of the above described results and previous ¢ndings,
we asked whether BMP7 functions in synergy with LIF to
induce astrocyte di¡erentiation of fetal brain cells. As shown
in Fig. 2H, when neuroepithelial cells were treated with BMP7
and LIF simultaneously for 2 days, cells positive for astrocyte
hallmark protein, GFAP, with typical astrocyte morphologies
were induced. In contrast, no GFAP-positive cell was ob-
served in the culture with BMP7 or LIF alone (Fig. 2F and
G). BMP7 and LIF did not appear to signi¢cantly a¡ect the
number of neuroepithelial cells as assessed by nuclear staining
with H33258 (Fig. 2A^D). These results indicate that BMP7
with LIF can synergistically induce astrocyte di¡erentiation of
neuroepithelial cells, as has been reported for a combination
of BMP2 and LIF.
3.3. Requirement of Smads, STAT3 and p300 in synergistic
astrocyte induction by BMP7 and IL-6 family of cytokines
LIF and IL-6 transduce their signals through either gp130/
LIFR heterodimer or gp130/gp130 homodimer, respectively,
and transcription factor STAT3. Therefore, we next tried to
assess whether BMP7 and IL-6 function in synergy to induce
astrocyte di¡erentiation from neuroepithelial cells. In the fol-
lowing experiments, sIL-6R was added to the culture with
IL-6 to e¡ectively stimulate gp130 on the cell surface [11].
As in the case of LIF (see Fig. 2), astrocyte di¡erentiation
was synergistically induced by a simultaneous addition of
BMP7 and IL-6 (Fig. 3H).
Smads and STAT3 have been demonstrated to be indispen-
sable for synergistic activation of the GFAP gene promoter by
BMP2 and LIF [6]. We thus examined whether Smads and
STAT3 are also prerequisite for the synergistic GFAP expres-
sion by BMP7 and IL-6. BMP7 and IL-6 synergistically in-
duced the GFAP promoter-driven luciferase expression in
neuroepithelial cells transfected with GF1L-pGL3 (‘vehicle’
in Fig. 3I), conforming to the results obtained by immunocy-
tochemistry. Smad6 is known as an inhibitory Smad molecule
which represses TGF-L and BMP signaling by inhibiting re-
ceptor-mediated phosphorylation of signal-speci¢c Smad spe-
cies or competing with Smad4 for binding to these Smad
proteins. Transfection of neuroepithelial cells with Smad6 re-
duced the promoter activation induced by either BMP7 or a
combination of BMP7 and IL-6 (Fig. 3I, hatched and ¢lled
columns in the middle four columns). A dominant negative
form of STAT3 (DN-STAT3) was further used, which has an
amino acid substitution on tyrosine705 to phenylalanine and
functions as an inhibitory molecule against endogenous
STAT3. Overexpression of this DN-STAT3 in neuroepithelial
Fig. 1. Expression of BMP7 in fetal mouse brain and neuroepithe-
lial cells. Total RNAs were extracted from fetal whole brain of
E17.5 mouse embryo (Brain) or 4 days cultured neuroepithelial cells
(NEC) from E14.5 mouse brain, and subjected to RT-PCR using
speci¢c primers for BMP7. M indicates molecular marker.
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cells inhibited the GFAP promoter activation induced by
BMP7 and IL-6 either alone or in combination (Fig. 3I, the
right three columns). These data suggest the requirement of
transcription factors, STAT3 and Smads, for synergistic as-
trocyte di¡erentiation induced by BMP7 and IL-6, implying
the existence of crosstalk between BMP7 and IL-6 signaling
via Smads and STAT3 transcription factors.
We have previously reported that a complex formation of
Smad1 and STAT3 bridged by a transcriptional coactivator
p300 is necessary for the synergistic induction of astrocyte
di¡erentiation by BMP2 and LIF [6]. Thus, we examined
the involvement of the Smad1/p300/STAT3 complex in the
synergistic astrocyte di¡erentiation induced by BMP7 and
IL-6 as well. p300 is known to interact with various kinds
of transcription factors and to function as a molecular glue
to form this complex. Recently we reported that p300 prefer-
entially binds to Smad1 and STAT3 at its COOH-terminal
and NH2-terminal regions, respectively. For this reason, two
p300 fragments, p300 (1737^2414) and p300 (1^682), have
been shown to compete with endogenous p300 for its binding
to Smad1 and STAT3, respectively, and to inhibit the GFAP
promoter activation induced by BMP2 and IL-6 when over-
expressed in neuroepithelial cells [6]. As shown in Fig. 3J, in
neuroepithelial cells co-transfected with GF1L-pGL3 and
p300 (1^682) or p300 (1737^2414), synergistic GFAP pro-
moter activation induced by BMP7 and IL-6 was severely
inhibited. This implies that p300-mediated complex formation
of Smad proteins and STAT3 is also involved in astrocyte
di¡erentiaton synergistically induced by BMP7 and IL-6.
Moreover, synergistic GFAP promoter activation by BMP7
and LIF was also inhibited by overexpression of DN-STAT3,
Smad6 or truncated form of p300 (data not shown), suggest-
ing that the Smads/p300/STAT3 complex plays a critical role
in common when BMP and IL-6 families of cytokines act in
synergy.
3.4. TGF-L is devoid of activity to induce astrocyte
di¡erentiation
Since we have observed expression of TGF-L1 (another
Fig. 3. Synergistic astrocyte di¡erentiation induced by BMP7 and
IL-6, and involvement of STAT3, Smads and p300. A^H: Neuro-
epithelial cells were cultured with either medium alone (A, E),
BMP7 (B, F), IL-6/sIL-6R (C, G), or a combination of BMP7 and
IL-6/sIL-6R (D, H) for 2 days and stained for DNA (A^D) and
GFAP (E^H), and the same ¢eld under each culture condition was
photographed. I, J: Neuroepithelial cells were co-transfected with
GF1L-pGL3, pEF-Rluc and either control vehicle or an expression
construct encoding DN-STAT3 or Smad6 (I), or truncated forms of
p300 (J). The cells were stimulated on the following day with
BMP7, IL-6/sIL-6R or a combination of BMP7 and IL-6/sIL-6R,
and luciferase activities in the cell lysates were measured.
Fig. 2. Synergistic astrocyte di¡erentiation induced by BMP7 and
LIF. Neuroepithelial cells from E14.5 mice were cultured with either
medium alone (A, E), BMP7 (B, F), LIF (C, G), or a combination
of BMP7 and LIF (D, H) for 2 days. Cells were stained for DNA
(A^D) and GFAP (E^H), and the same ¢eld under each culture
condition was photographed.
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member of the TGF-L superfamily to which the BMP family
belong), its cognate receptor components (TLR I and II) and
its downstream transcription factors (Smad2 and Smad3) in
neuroepithelial cells as in Fig. 4A, we asked whether TGF-L1
is capable of contributing to the induction of astrocyte di¡er-
entiation. We have previously indicated that exogenously
added BMP2 acts in synergy to induce astrocyte di¡erentia-
tion with endogenously expressed and accumulated IL-6 fam-
ily of cytokines in the culture, so that GFAP-positive astro-
cytes emerge when the cells were cultured for 6 days with
exogenously added BMP2 alone [7]. This is also the case for
BMP7 (Fig. 4B). However, TGF-L1 failed to induce astrocyte
di¡erentiation in this culture condition (Fig. 4B), even though
its receptor components and the downstream transcription
factors were detectable in neuroepithelial cells (Fig. 4A).
TGF-L1 activates Smad2 and Smad3 as ‘pathway-speci¢c
Smads’ but not Smad1, Smad5 and Smad8 that are BMP
pathway-speci¢c [10]. Hence, it is likely that the activation
of BMP pathway-speci¢c Smads is required for the synergistic
astrocyte induction with IL-6 family cytokines.
4. Discussion
In the present study, we found that BMP7 as well as BMP2
induce astrocyte di¡erentiation in synergy with IL-6 family of
cytokine, LIF or IL-6, and tried to elucidate the molecular
mechanism underlying this phenomenon. We have demon-
strated the critical role of Smads and STAT3 in this syner-
gistic astrocyte induction because synergistic GFAP promoter
activation by BMP7 and LIF or IL-6 was inhibited by over-
expression of Smad6 or DN-STAT3. LIF and IL-6 are known
to signal via di¡erent types of gp130-containing dimers, i.e.
gp130/LIFR heterodimer and gp130/gp130 homodimer, re-
spectively, yet both of these dimer formations lead to the
activation of STAT3 [11]. Accordingly, STAT3 activation is
ultimately important, regardless of the type of dimer forma-
tion, for the IL-6 family of cytokines to participate in astro-
cyte di¡erentiation. As for BMPs, BMP pathway-speci¢c
Smads are essential to induce astrocyte di¡erentiation, be-
cause TGF-L1, which activates TGF-L pathway-speci¢c
Smads, Smad2 and Smad3, is incapable of inducing astrocyte
di¡erentiation. The synergistic e¡ect between BMP and IL-6
family of cytokines to induce astrocyte di¡erentiation ob-
served in the present in vitro culture system seems to function
in vivo as well, since these cytokines and their receptor com-
ponents are expressed together in developing brain [7^9,13]. In
support of this idea, GFAP-positive astrocytes were severely
reduced in fetal mouse brain de¢cient for gp130 even though
the expression of BMPs and their receptor component was
intact [5,7].
Supposing that various factors which regulate cell fate de-
termination may exist at the same time in the developing
brain, it is important to take the signaling crosstalk into con-
sideration for the better understanding of in vivo function of
these factors in the brain development. We have reported the
molecular mechanism whereby BMPs and the IL-6 family of
cytokines function in synergy to promote astrocytogenesis.
Smads and STAT3 form a complex in response to this cyto-
kine stimulation with a help of p300, and this complex for-
mation is essential to e¡ectively activate the target gene tran-
scription. Considering that p300 is capable of associating with
a variety of transcription factors, other signaling crosstalks in
which p300 is involved may exist.
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